Clinical Trial

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
An Open Label Long-Term Study to Evaluate the Safety and Effectiveness of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-10; most recent amendment 2025-07-01.
Trial Details
NCT Number NCT06365424
Lead Sponsor Xijing Hospital of Digestive Diseases
Conditions Primary Biliary Cholangitis
Enrollment 117 participants
Start Date 2017-04-08
Primary Completion 2027-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2025-07-02